ORTX - Orchard Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue2,076--
Cost of Revenue422--
Gross Profit1,654--
Operating Expenses
Research Development205,31932,52716,206
Selling General and Administrative31,3665,9852,997
Non Recurring---
Others---
Total Operating Expenses237,10738,51219,203
Operating Income or Loss-235,031-38,512-19,203
Income from Continuing Operations
Total Other Income/Expenses Net5,506-1,179138
Earnings Before Interest and Taxes-235,031-38,512-19,203
Interest Expense---
Income Before Tax-229,525-39,691-19,065
Income Tax Expense9705320
Minority Interest---
Net Income From Continuing Ops-230,495-39,744-19,085
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-230,495-39,744-19,085
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-230,495-39,744-19,085